< Arab Finance - News - Memphis Pharmaceutical’s board OKs EGP 171.25M capital hike
Count Down to relaunch



Memphis Pharmaceutical’s board OKs EGP 171.25M capital hike

Memphis Pharmaceutical’s board OKs EGP 171.25M capital hike

Arab Finance: The board of directors of Memphis Pharmaceutical (MPCI) approved an EGP 171.25 million increase in the issued and paid-up capital, according to a filing to the Egyptian Exchange (EGX) on Sunday.

Accordingly, the company’s issued and paid-up capital will be increased to EGP 227.5 million from EGP 56.25 million.

The capital increase will be financed by HoldiPharma and ordinary shareholders.

Memphis is one of the oldest pharmaceutical and chemical companies in the Middle East and has been in the market since 1940.

Recommended Stocks

13 Jun 2022
Delta Sugar SUGR
Close
22.35
Change
-03.54
Hold

All rights reserved to Arab Finance 2020 ©

Back to top